4.4 Review

Commonly studied single-nucleotide polymorphisms and breast cancer: Results from the Breast Cancer Association Consortium

Journal

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
Volume 98, Issue 19, Pages 1382-1396

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/jnci/djj374

Keywords

-

Categories

Funding

  1. Intramural NIH HHS Funding Source: Medline
  2. NCI NIH HHS [CA69664, R01 CA47305, R01 CA67338, R01 CA67264, CA47147, CA-95-003] Funding Source: Medline
  3. Breast Cancer Now [BREAST CANCER NOW RESEARCH CENTRE] Funding Source: Medline

Ask authors/readers for more resources

Background. The Breast Cancer Association Consortium (BCAC) is an international collaboration that was established to provide large sample sizes for examining genetic associations. We conducted combined analyses on all single-nucleotide polymorphisms (SNPs) whose associations with breast cancer have been investigated by at least three participating groups. Methods: Data from up to 12 studies were pooled for each SNP (ADH1C I350V, AURKA F31I, BRCA2 N372H, CASP8 D302H, ERCC2 D312N, IGFBP3 -202 c > a, LIG4 D501D, PGR V660L, SOD2 V16A, TGFBI L10P, TP53 R72P XRCC1 R399Q, XRCC2 R188H, XRCC3 T241M, XRCC3 51 UTR, and XRCC3 IVS7-14). Genotype frequencies in case and control subjects were compared, and genotype-specific odds ratios for the risk of breast cancer in heterozygotes and homozygotes for the rare allele compared with homozygotes for the common allele were estimated with logistic regression. Statistical tests were two-sided. Results: The total number of subjects for analysis of each SNP ranged from 12013 to 31595. For five SNPs-CASP8 D302H, IGFBP3 -202 c > a, PGR V660L, SOD2 V16A, and TGFBI L10P-the associations with breast cancer were of borderline statistical significance (P = .016, .060, .047, .056, and .0088 respectively). The remaining 11 SNPs were not associated with breast cancer risk; genotype-specific odds ratios were close to unity. There was some evidence for between-study heterogeneity (P <.05) for four of the 11 SNPs (ADH1C I350V, ERCC2 D312N, XRCC1 R399Q, and XRCC3 IVS5-14). Conclusion: Pooling data within a large consortium has helped to clarify associations of SNPs with breast cancer. In the future, consortia such as the BCAC will be important in the analysis of rare polymorphisms and gene x gene or gene x environment interactions, for which individual studies have low power to identify associations, and in the validation of associations identified from genome-wide association studies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available